Free public records show AFT Pharmaceuticals, Ltd. in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by AFT Pharmaceuticals, Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
4 active studies led by AFT Pharmaceuticals, Ltd., of 9 in all
Source: ClinicalTrials.gov, Studies with AFT Pharmaceuticals, Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
1 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Studies AFT Pharmaceuticals, Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with AFT Pharmaceuticals, Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show AFT Pharmaceuticals, Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets AFT Pharmaceuticals, Ltd. is in.
Stories on the topics AFT Pharmaceuticals, Ltd. works in.
170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Read
About 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…
Read
The FDA has approved one cannabis-derived medicine, Epidiolex, for rare epilepsies, and three synthetic…
ReadSearch all reports for AFT Pharmaceuticals, Ltd. All companies